125 related articles for article (PubMed ID: 38654493)
21. Trends in Health Care-Associated Infection Prevention Practices in US Veterans Affairs Hospitals From 2005 to 2017.
Vaughn VM; Saint S; Greene MT; Ratz D; Fowler KE; Patel PK; Krein SL
JAMA Netw Open; 2020 Feb; 3(2):e1920464. PubMed ID: 32022877
[TBL] [Abstract][Full Text] [Related]
22. National survey of practices to prevent healthcare-associated infections in Thailand: the role of safety culture and collaboratives.
Apisarnthanarak A; Greene MT; Kennedy EH; Khawcharoenporn T; Krein S; Saint S
Infect Control Hosp Epidemiol; 2012 Jul; 33(7):711-7. PubMed ID: 22669233
[TBL] [Abstract][Full Text] [Related]
23. Reduction of central line-associated bloodstream infections in a large acute care hospital in Midwest United States following implementation of a comprehensive central line insertion and maintenance bundle.
Wei AE; Markert RJ; Connelly C; Polenakovik H
J Infect Prev; 2021 Sep; 22(5):186-193. PubMed ID: 34659456
[TBL] [Abstract][Full Text] [Related]
24. Quantitative Results of a National Intervention to Prevent Central Line-Associated Bloodstream Infection: A Pre-Post Observational Study.
Patel PK; Greene MT; Jones K; Rolle AJ; Ratz D; Snyder A; Saint S; Chopra V
Ann Intern Med; 2019 Oct; 171(7_Suppl):S23-S29. PubMed ID: 31569230
[TBL] [Abstract][Full Text] [Related]
25. CLABSI Conversations: Lessons From Peer-to-Peer Assessments to Reduce Central Line-Associated Bloodstream Infections.
Pham JC; Goeschel CA; Berenholtz SM; Demski R; Lubomski LH; Rosen MA; Sawyer MD; Thompson DA; Trexler P; Weaver SJ; Weeks KR; Pronovost PJ
Qual Manag Health Care; 2016; 25(2):67-78. PubMed ID: 27031355
[TBL] [Abstract][Full Text] [Related]
26. Best products for skin antisepsis.
Boyce JM
Am J Infect Control; 2023 Nov; 51(11S):A58-A63. PubMed ID: 37890954
[TBL] [Abstract][Full Text] [Related]
27. [The Incidences of Catheter Colonization and Central Line-Associated Bloodstream Infection According to Tegaderm vs. Chlorhexidine Gluconate (CHG)-Tegaderm Dressing].
Kim E; Lee H
J Korean Acad Nurs; 2020 Aug; 50(4):541-553. PubMed ID: 32895341
[TBL] [Abstract][Full Text] [Related]
28. 0.2% chlorhexidine acetate as skin disinfectant prevents skin lesions in extremely preterm infants: a preliminary report.
Janssen LMA; Tostmann A; Hopman J; Liem KD
Arch Dis Child Fetal Neonatal Ed; 2018 Mar; 103(2):F97-F100. PubMed ID: 28468901
[TBL] [Abstract][Full Text] [Related]
29. Bathing With 2% Chlorhexidine Gluconate: Evidence and Costs Associated With Central Line-Associated Bloodstream Infections.
Shah HN; Schwartz JL; Luna G; Cullen DL
Crit Care Nurs Q; 2016; 39(1):42-50. PubMed ID: 26633158
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Rates of Central Line-Associated Bloodstream Infections in Patients With 1 vs 2 Central Venous Catheters.
Dube WC; Jacob JT; Zheng Z; Huang Y; Robichaux C; Steinberg JP; Fridkin SK
JAMA Netw Open; 2020 Mar; 3(3):e200396. PubMed ID: 32129868
[TBL] [Abstract][Full Text] [Related]
31. Preventing device-associated infections in US hospitals: national surveys from 2005 to 2013.
Krein SL; Fowler KE; Ratz D; Meddings J; Saint S
BMJ Qual Saf; 2015 Jun; 24(6):385-92. PubMed ID: 25862757
[TBL] [Abstract][Full Text] [Related]
32. Chlorhexidine locking device for central line infection prevention in ICU patients: protocol for an open-label pilot and feasibility randomized controlled trial.
Zamir N; Pook M; McDonald E; Fox-Robichaud AE
Pilot Feasibility Stud; 2020; 6():26. PubMed ID: 32099661
[TBL] [Abstract][Full Text] [Related]
33. Best products for skin antisepsis.
Boyce JM
Am J Infect Control; 2019 Jun; 47S():A17-A22. PubMed ID: 31146845
[TBL] [Abstract][Full Text] [Related]
34. Central-line associated bloodstream infections in intensive care units before and after implementation of daily antiseptic bathing with chlorhexidine or octenidine: a post-hoc analysis of a cluster-randomised controlled trial.
Denkel LA; Schwab F; Clausmeyer J; Behnke M; Golembus J; Wolke S; Gastmeier P; Geffers C;
Antimicrob Resist Infect Control; 2023 Jun; 12(1):55. PubMed ID: 37270604
[TBL] [Abstract][Full Text] [Related]
35. Impact of unit-wide chlorhexidine bathing in intensive care on bloodstream infection and drug-resistant organism acquisition.
Urbancic KF; Mårtensson J; Glassford N; Eyeington C; Robbins R; Ward PB; Williams D; Johnson PD; Bellomo R
Crit Care Resusc; 2018 Jun; 20(2):109-116. PubMed ID: 29852849
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the effectiveness of chlorhexidine bathing and health care-associated infections among adult intensive care patients: a trial sequential meta-analysis.
Frost SA; Hou YC; Lombardo L; Metcalfe L; Lynch JM; Hunt L; Alexandrou E; Brennan K; Sanchez D; Aneman A; Christensen M
BMC Infect Dis; 2018 Dec; 18(1):679. PubMed ID: 30567493
[TBL] [Abstract][Full Text] [Related]
37. Characteristics, costs, and outcomes associated with central-line-associated bloodstream infection and hospital-onset bacteremia and fungemia in US hospitals.
Yu KC; Jung M; Ai C
Infect Control Hosp Epidemiol; 2023 Dec; 44(12):1920-1926. PubMed ID: 37424226
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit.
Popovich KJ; Hota B; Hayes R; Weinstein RA; Hayden MK
Infect Control Hosp Epidemiol; 2009 Oct; 30(10):959-63. PubMed ID: 19712033
[TBL] [Abstract][Full Text] [Related]
39. A multicenter quasi-experimental study: impact of a central line infection control program using auditing and performance feedback in five Belgian intensive care units.
Cherifi S; Gerard M; Arias S; Byl B
Antimicrob Resist Infect Control; 2013 Dec; 2(1):33. PubMed ID: 24308851
[TBL] [Abstract][Full Text] [Related]
40. Comparative Effectiveness of 2 Chlorhexidine Gluconate-Containing Dressings in Reducing Central Line-Associated Bloodstream Infections, Hospital Stay, and Costs.
Hou Y; Griffin L; Bernatchez SF; Hommes J; Kärpänen T; Palka-Santini M
Inquiry; 2023; 60():469580231214751. PubMed ID: 38037829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]